Shamim Ruff is a director of Reata Pharmaceuticals Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
REATA PHARMACEUTICALS INC
26 Sep 23
4
REATA PHARMACEUTICALS INC
1 Aug 23
144
REATA PHARMACEUTICALS INC
28 Jul 23
4
REATA PHARMACEUTICALS INC
9 Jun 23
4
REATA PHARMACEUTICALS INC
13 Mar 23
4
REATA PHARMACEUTICALS INC
9 Jun 22
4
REATA PHARMACEUTICALS INC
5 Jan 22
4
REATA PHARMACEUTICALS INC
14 Jun 21
4
REATA PHARMACEUTICALS INC
16 Apr 21
3
REATA PHARMACEUTICALS INC
15 Apr 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
26 Sep 23 | RETA Reata Pharmaceuticals | Class A common stock | Sale back to company | Dispose D | No | No | 0 | 7,359 | 0.00 | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Stock Option Class A common stock | Sale back to company | Dispose D | No | No | 93.61 | 2,137 | 200.04 k | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Stock Option Class A common stock | Sale back to company | Dispose D | No | No | 93.61 | 576 | 53.92 k | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Stock Option Class A common stock | Sale back to company | Dispose D | No | No | 34.76 | 1,405 | 48.84 k | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Stock Option Class A common stock | Sale back to company | Dispose D | No | No | 34.76 | 443 | 15.40 k | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Stock Option Class A common stock | Sale back to company | Dispose D | No | No | 146.01 | 780 | 113.89 k | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Stock Option Class A common stock | Sale back to company | Dispose D | No | No | 146.01 | 5,000 | 730.05 k | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Stock Option Class A common stock | Sale back to company | Dispose D | No | No | 92.2 | 3,334 | 307.39 k | 0 |
28 Jul 23 | RETA Reata Pharmaceuticals | Class A common stock | Sell | Dispose S | No | Yes | 164.5279 | 8,235 | 1.35 mm | 7,359 |
28 Jul 23 | RETA Reata Pharmaceuticals | Class A common stock | Option exercise | Acquire M | No | No | 92.2 | 319 | 29.41 k | 15,594 |